Development and validation of a 0.5 mg dexamethasone suppression test as an initial screening test for the diagnosis of ACTH-dependent Cushing's syndrome

Endocrine Journal

Volumn 56, Issue 7, 2009, Pages 897-904

  Oki, Yutaka ^a   Hashimoto, Kozo ^b   Hirata, Yukio ^c   Iwasaki, Yasumasa ^b   Nigawara, Takeshi ^d   Doi, Masaru ^c   Sakihara, Satoru ^d   Kageyama, Kazunori ^d   Suda, Toshihiro ^d  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOCHI UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d HIROSAKI UNIVERSITY   (Japan)

Author keywords

ACTH dependent Cushing's syndrome; Cushing's disease; Dexamethasone suppression test; Screening

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; DEXAMETHASONE SUPPRESSION TEST; DRUG DOSE COMPARISON; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY;

ACTH SYNDROME, ECTOPIC; ADULT; CUSHING SYNDROME; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; SENSITIVITY AND SPECIFICITY;

EID: 70350666504     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-194     Document Type: Article

References (34)

1. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593-5602. (Pubitemid 38033020)
2. Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, Nadeem S, Ennis R, Erwin PJ, Montori VM (2008) Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab 93:1553-1562. (Pubitemid 351656487)
3. Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F (1999) Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 84:440-448.
4. Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing's syndrome. Lancet 367:1605-1617.
5. Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 19:647-672. (Pubitemid 28467716)
6. Reimondo G, Pia A, Bovio S, Allasino B, Daffara F, Paccotti P, Borretta G, Angeli A, Terzolo M (2008) Laboratory differentiation of Cushing's syndrome. Clin Chim Acta 388:5-14.
7. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526-1540. (Pubitemid 351656485)
8. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W (1992) Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 75:826-832.
9. Terzolo M, Osella G, Ali A, Borretta G, Cesario F, Paccotti P, Angeli A (1998) Subclinical Cushing's syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 48:89-97. (Pubitemid 28122438)
10. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G (2000) Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85:1440-1448. (Pubitemid 32289484)
11. Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T, Sasano H (2001) Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes. Endocr J 48:167-174. (Pubitemid 32499749)
12. Nagai T, Imamura M, Misumi S, Mori M (2002) Subclinical Cushing's disease accompanied by malignant hypertension and diabetes mellitus. Intern Med 41:566-570. (Pubitemid 34846258)
13. Kageyama K, Moriyama T, Sakihara S, Kawashima S, Suda T (2003) A case of preclinical Cushing's disease, accompanied with thyroid papillary carcinoma and adrenal incidentaloma. Endocr J 50:325-331. (Pubitemid 36830010)
14. Ohmori N, Nomura K, Ohmori K, Takano K (2007) Preclinical Cushing's disease characterized by massive adrenal hyperplasia and hormonal changes after three years of metyrapone therapy. Endocr J 54:391-397.
15. Liddle GW (1960) Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 20:1539-1560.
16. Nugent CA, Nichols T, Tyler FH (1965) Diagnosis of Cushing's Syndrome; Single Dose Dexamethasone Suppression Test. Arch Intern Med 116:172-176.
17. Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M, Colao A, Toja PM, Lombardi G, Cavagnini F (2007) The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Clin Endocrinol (Oxf) 66:251-257. (Pubitemid 46096146)
18. Blethen SL, Chasalow FI (1989) Overnight dexamethasone suppression test: normal responses and the diagnosis of Cushing's syndrome. Steroids 54:185-193.
19. Findling JW, Raff H, Aron DC (2004) The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. J Clin Endocrinol Metab 89:1222-1226. (Pubitemid 38368417)
20. Gorges R, Knappe G, Gerl H, Ventz M, Stahl F (1999) Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group. J Endocrinol Invest 22:241-249. (Pubitemid 29224321)
21. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B (1997) Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome - recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34 (Pt 3):222-229. (Pubitemid 27236924)
22. Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A (2003) Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab 88:5808-5813. (Pubitemid 38033055)
23. Tauchmanova L, Rossi R, Nuzzo V, del Puente A, Esposito-del Puente A Pizzi C, Fonderico F, Lupoli G, Lombardi G (2001) Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. Eur J Endocrinol 145:241-247. (Pubitemid 32825656)
24. Ambrosi B, Peverelli S, Passini E, Re T, Ferrario R, Colombo P, Sartorio A, Faglia G (1995) Abnormalities of endocrine function in patients with clinically "silent" adrenal masses. Eur J Endocrinol 132:422-428.
25. Pecori Giraldi F, Ambrogio AG, De Martin M, Fatti LM, Scacchi M, Cavagnini F (2007) Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series. J Clin Endocrinol Metab 92:4123-4129. (Pubitemid 350074721)
26. Sakai Y, Horiba N, Tozawa F, Sakai K, Kuwayama A, Demura H, Suda T (1997) Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing's syndrome. Endocr J 44:687-695. (Pubitemid 28011457)
27. Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Jr., Loriaux DL (1984) The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med 310:622-626. (Pubitemid 14151190)
28. Kaye TB, Crapo L (1990) The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 112:434-444.
29. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB, Jr., Loriaux DL (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 325:897-905.
30. Orth DN, DeBold CR, DeCherney GS, Jackson RV, Alexander AN, Rivier J, Rivier C, Spiess J, Vale W (1982) Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. J Clin Endocrinol Metab 55:1017-1019.
31. Suda T, Kageyama K, Nigawara T, Sakihara S (2009) Evaluation of Diagnostic Tests for ACTH-Dependent Cushing's Syndrome. Endocr J 56:469-476.
32. Teramoto A, Nemoto S, Takakura K, Sasaki Y, Machida T (1993) Selective venous sampling directly from cavernous sinus in Cushing's syndrome. J Clin Endocrinol Metab 76:637-641. (Pubitemid 23086479)
33. Doi M, Sekizawa N, Tani Y, Tsuchiya K, Kouyama R, Tateno T, Izumiyama H, Yoshimoto T, Hirata Y (2008) Late-night salivary cortisol as a screening test for the diagnosis of Cushing's syndrome in Japan. Endocr J 55:121-126.
34. Odagiri E, Naruse M, Terasaki K, Yamaguchi N, Jibiki K, Takagi S, Tanabe M, Takano K (2004) The diagnostic standard of preclinical Cushing's syndrome: evaluation of the dexamethasone suppression test using various cortisol kits. Endocr J 51:295-302. (Pubitemid 38981068)